T o the editor: A 97-year-old female was admitted to the local hospital on June 12th, 2010. She complained of suffering an asthma-like breathing difficulty for about 3 months and it was getting worse for the last 10 days. Computed tomography (CT) scan showed an isolated lesion in main branch of the trachea ( Figure 1A) . Considering the complexity of the case, the patient was transfered to our hospital. Ultrasound showed that the size of the right thyroid increased, consistent with non-uniform density and abundant blood flow. The results of lab examination of thyroid function were normal. All these auxiliary examinations indicated a malignant tumor of thyroid protruded into the trachea. Consider of the patient's age, conventional operation was not practical. Although the patient suffered high blood pressure and diabetes, they were well controlled at that time. During hospitalization in the local hospital, a nutritional supplement, oxygen inhalation and monitoring of blood pressure and blood sugar had been performed. The condition of the patient had been improved and she could bear supine position for a short time that made it possible to do a tracheotomy. After a comprehensive study of the patient's case, we decided to give her a minimally invasive surgery. On June 30th, 2010 the patient underwent tracheotomy and trachea tumor resection assisted by endoscope under intravenous induction of anesthesia. Because the patient could maintain supine positon only for a short time, the tracheotomy should be finished quickly and oxygen mask was necessary to ensure safety. We put the endoscope through the tracheal fistula to examine the inside of tracheal. A smooth mass of 1.5 cm × 1.5 cm × 1.0 cm which was 2.0 cm below the tracheal fistula was taken out without causing tracheal cartilage collapsing. The root of the tumor in connection with the thyroid was 0.5 cm in diameter. The postoperative pathology confirmed papillary thyroid carcinoma invading the trachea. After the operation the patient took oral thyroxine (Euthyrox, Merck & Co. Inc., Germany) from 100 μg/d to inhibit the development of tumor. Thyroid stimulating hormone (TSH), T3, T4 were measured every 4 weeks until TSH was suppressed to the level of 0.1-0.5 mU/L. The patient's thyroid function and ultrasound image were monitored every 3-6 months after the oral dose was stable. In the most recent follow-up which was almost four years after the operation, the thyroid tumors showed no significant progress and the patient had not suffered any breathing difficulty. CT scan also revealed no significant tracheal stenosis ( Figure 1B) . The case is being further monitored.
In clinical practice, it is more difficult to deal with a thyroid cancer with trachea protrusion. Honings et al 1 suggested that tracheal resection should be performed in this kind of patients. But the tracheal resection would cause severe surgical trauma and postoperative complications which the centenarian could not bear. In this case the patient's symptoms were relieved and only suffered a minimal surgical trauma by a new simple operation. This surgical approach only requires the patient to stay in a supine position in a short time to take the tracheotomy, and then the tumor of the trachea can be excised by endoscope. Given the patient's life expectancy at this point in addition to a characteristically more frail overall state of health, more radical treatment seemed inappropriate. Taking into account the relatively slow development of papillary thyroid cancer, we formulated a treatment plan which combined endotracheal tumor resection and TSH suppression therapy. Thyroxine dose was adjusted according to the level of TSH testing. The appropriate dose should be high enough to suppress TSH secretion while maintaining normal thyroid function. Usually plasma TSH concentration was maintained at 0.1-0.5 mU/L. For high-risk patients, TSH should be maintained at a level below 0.1 mU/L. However, it was reported that the probability of heart failure increased significantly in the elders who suffered subclinical hyperthyroidism. 2 So in this case, the TSH suppression was maintained at 0.1-0.5 mU/L to avoid subclinical hyperthyroidism. The patient has been followed up for the last four years after surgery. There was no significant progress of thyroid tumor, and no tracheal tumor recurrence. This successful case provides a new clinical approach to treat patients with poor physical conditions and thyroid tumors with trachea invasion.
